Inventor · disambiguated record
Lars A. Akslen
Also filed as: AKSLEN LARS A · AKSLEN LARS ANDREAS
0 granted patents·10 pending applications·0 citations·filing 2010–2023
Files withBERGEN TEKNOLOGIOVERFORING AS3CARTER SCOTT L2VESTLANDETS INNOVASJONSSELSKAP AS2LORENS JAMES BRADLEY1PRELUDE CORP1
Top patents by PatentIndex Score
10 records- 0162US2018246080A1Methods using axl as a biomarker of epithelial-to-mesenchymal transitionBERGEN TEKNOLOGIOVERFORING AS·Filed 2017·Application pending·0 cites
- 0261US2015212065A1Methods using Axl as a biomarker of epithelial-to-mesenchymal transitionBERGEN TEKNOLOGIOVERFORING AS·Filed 2014·Application pending·0 cites
- 0360US2025011874A1Breast cancer prognosis and stratificationVESTLANDETS INNOVASJONSSELSKAP AS·Filed 2023·Application pending·0 cites
- 0447US2014200155A1Prognostic marker for endometrial carcinomaBERGEN TEKNOLOGIOVERFORING AS·Filed 2014·Application pending·0 cites
- 0547US2023392209A1Methods for treating a subject with local invasive breast cancer based on pdgfrb levelsPRELUDE CORP·Filed 2021·Application pending·0 cites
- 0647US2012159655A1Methods using axl as a biomarker of epithelial-to-mesenchymal transitionLORENS JAMES BRADLEY·Filed 2010·Application pending·0 cites
- 0743US2013338026A1Prognostic Marker for Endometrial CarcinomaCARTER SCOTT L·Filed 2013·Application pending·0 cites
- 0838US2011217701A1Prognostic Marker for Endometrial CarcinomaCARTER SCOTT L·Filed 2010·Application pending·0 cites
- 0929US2021047418A1Antibody against alpha-11 integrin and its useVESTLANDETS INNOVASJONSSELSKAP AS·Filed 2019·Application pending·0 cites
- 1027US2013267440A1Marker for carcinomaSALVESEN HELGA B·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lars A. Akslen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →